Abstract: Disclosed is a system and method for monitoring, diagnosing, and treating certain medical conditions, such as asthma, gastroesophageal reflux or laryngopharyngeal reflux. The system includes a mask apparatus or sensor module fitted with a pH sensor and thermocouple, a continuous positive airway pressure (CPAP) device, a processing receiver, and a therapeutic nebulizer/atomizer/humidifier device. The mask apparatus, CPAP device and therapeutic nebulizer/atomizer/humidifier device are connected by a pneumatic means. The pH sensor and the thermocouple are in electrical communication with the processing receiver that controls, through an electronic means, the CPAP device and therapeutic nebulizer/atomizer/humidifier device. The electrical communications can be in the form of a plurality of wires or employ wireless means.

Abstract: The present invention discloses a sphygmomanometer having 3D positioning function, which comprises a microprocessor chip which is coupled individually to a microprocessor chip which is coupled individually to a pressure sensor, an alarm unit, a storing unit, a 3D acceleration sensor chip, a display device, a driving device, and an air valve, so that when a person's blood pressure is measured, the 3D acceleration sensor chip detects the spatial position of the measuring cuff of the sphygmomanometer and sends the parameters related to the detected spatial position to the microprocessor chip. In the meantime, the microprocessor chip will retrieve a predetermined range of the parameters related to the spatial position from the storing unit, and compare such range with the value of the detected parameters. If the values of the detected parameters fall beyond the predetermined range of parameters, the microprocessor chip will issue an alarm through the alarm unit until the spatial position is correct.

Abstract: A method, apparatus and procedure for the non-invasive detection of the sugar concentration changes in body liquids such as blood is disclosed. The instrument measures sugar concentration changes using the natural fingerprint of sugar which is rotations of polarization of light emitted from the biological particle chromophores dissolved together with sugar in human liquids. The degree of polarization of light emitted from luminescence centers undergoing interaction with an optically active medium such as sugar is proportional to the concentration of sugar in, for example, blood. The reference level is determined by conventional blood analysis using standard monitoring equipment during the special procedure of the Glucose Tolerance Test.